[Place of consensus type interferon alpha in the management of chronic type C hepatitis].
This paper presents the results of clinical investigations of efficacy of consensus type interferon (Alfacon-1) in monotherapy, as well as in combination with ribavirin. A special indication for this kind of interferon are "difficult" patients with high virial load non-responders for previous treatment, as well as with recurrence of infection.
Juszczyk
Jacek
J
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D032921:Consensus; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin